Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates that proteinase-driven fibrinogen cleavage activates TLR4 in airway cells, suggesting allergic disease originates as an antifungal defense mechanism.
Proteinases and the innate immune receptor Toll-like receptor 4 (TLR4) are essential for expression of allergic inflammation and diseases such as asthma. A mechanism that links these inflammatory mediators is essential for explaining the fundamental basis of allergic disease but has been elusive. Here, we demonstrate that TLR4 is activated by airway proteinase activity to initiate both allergic airway disease and antifungal immunity. These outcomes were induced by proteinase cleavage of the clotting protein fibrinogen, yielding fibrinogen cleavage products that acted as TLR4 ligands on airway epithelial cells and macrophages. Thus, allergic airway inflammation represents an antifungal defensive strategy that is driven by fibrinogen cleavage and TLR4 activation. These findings clarify the molecular basis of allergic disease and suggest new therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Millien et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: